Clinical Trial Update: Two Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated two doses of conjugated estrogens (Premarin) in patients with prostate cancer that is resistant to androgen deprivation therapy. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• PREMARIN (Conjugated estrogens)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED